Julie Roques

2.1k total citations
17 papers, 748 citations indexed

About

Julie Roques is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Julie Roques has authored 17 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Julie Roques's work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Julie Roques is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Julie Roques collaborates with scholars based in France, Argentina and United States. Julie Roques's co-authors include Juan Iovanna, Marion Rubis, Nelson Dusetti, Sophie Lac, Martin Bigonnet, Richard Tomasini, Odile Gayet, Véronique Secq, Marie‐Noëlle Lavaut and Sophie Vasseur and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Julie Roques

17 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Roques France	12	452	352	307	110	102	17	748
Shereen Keleg Germany	16	463 1.0×	581 1.7×	184 0.6×	73 0.7×	115 1.1×	20	917
Leilei Tao China	11	358 0.8×	407 1.2×	306 1.0×	158 1.4×	51 0.5×	18	765
Wasfi Alrawashdeh United Kingdom	7	257 0.6×	203 0.6×	164 0.5×	62 0.6×	94 0.9×	13	514
Julia Mitschke Germany	6	464 1.0×	545 1.5×	351 1.1×	102 0.9×	53 0.5×	7	890
Saswati Karmakar United States	12	301 0.7×	467 1.3×	165 0.5×	127 1.2×	55 0.5×	20	692
Johannes von Burstin Germany	9	368 0.8×	445 1.3×	129 0.4×	53 0.5×	117 1.1×	13	741
Sladjana Zagorac Spain	10	475 1.1×	484 1.4×	239 0.8×	76 0.7×	91 0.9×	15	792
Victoire Gouirand United States	8	286 0.6×	404 1.1×	410 1.3×	302 2.7×	114 1.1×	10	892
Junko Matsuoka Japan	11	371 0.8×	377 1.1×	230 0.7×	75 0.7×	84 0.8×	25	692
Debolina Ganguly United States	10	399 0.9×	297 0.8×	171 0.6×	215 2.0×	60 0.6×	13	687

Countries citing papers authored by Julie Roques

Since Specialization

Citations

This map shows the geographic impact of Julie Roques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Roques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Roques more than expected).

Fields of papers citing papers by Julie Roques

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Roques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Roques. The network helps show where Julie Roques may publish in the future.

Co-authorship network of co-authors of Julie Roques

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Roques. A scholar is included among the top collaborators of Julie Roques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Roques. Julie Roques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kaoutari, Abdessamad El, Nicolás A. Fraunhoffer, Stéphane Audebert, et al.. (2023). Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers. EBioMedicine. 92. 104634–104634. 6 indexed citations

Fraunhoffer, Nicolás A., Martin Bigonnet, Odile Gayet, et al.. (2022). Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction. npj Precision Oncology. 6(1). 57–57. 14 indexed citations

Chuluyán, Eduardo, Nicolás A. Fraunhoffer, Diego Guerrieri, et al.. (2022). Secretory leukocyte proteinase inhibitor: A key player in the dialogue between the tumor and its microenvironment in pancreatic cancer patients.. Journal of Clinical Oncology. 40(4_suppl). 592–592. 2 indexed citations

Fraunhoffer, Nicolás A., Abdessamad El-Kaoutari, Odile Gayet, et al.. (2021). Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models. Cancers. 13(10). 2473–2473. 8 indexed citations

Kaoutari, Abdessamad El, Nicolás A. Fraunhoffer, Philippe Soubeyran, et al.. (2021). Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance. EBioMedicine. 66. 103332–103332. 32 indexed citations

Kaoutari, Abdessamad El, Françoise Silvy, Marion Rubis, et al.. (2021). A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. EBioMedicine. 71. 103541–103541. 31 indexed citations

Soubeyran, Philippe, Stéphane Audebert, Luc Camoin, et al.. (2021). TNF-α induces endothelial–mesenchymal transition promoting stromal development of pancreatic adenocarcinoma. Cell Death and Disease. 12(7). 649–649. 57 indexed citations

Fraunhoffer, Nicolás A., Martin Bigonnet, Odile Gayet, et al.. (2020). Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib. Clinical Cancer Research. 26(20). 5506–5519. 21 indexed citations

Juiz, Natalia, Abdessamad El-Kaoutari, Martin Bigonnet, et al.. (2020). Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtype. The FASEB Journal. 34(9). 12214–12228. 86 indexed citations

10.

Bian, Benjamin, Natalia Juiz, Odile Gayet, et al.. (2019). Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi). Frontiers in Oncology. 9. 475–475. 31 indexed citations

11.

Masoud, Rawand, Yolande Berthois, Stéphane Audebert, et al.. (2019). PML hyposumoylation is responsible for the resistance of pancreatic cancer. The FASEB Journal. 33(11). 12447–12463. 12 indexed citations

12.

Bressy, Christian, Sophie Lac, Jérémy Nigri, et al.. (2017). LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. Cancer Research. 78(4). 909–921. 82 indexed citations

13.

Olivares, O. Porta, Jared R. Mayers, Victoire Gouirand, et al.. (2017). Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nature Communications. 8(1). 16031–16031. 309 indexed citations

14.

Nigri, Jérémy, Meritxell Gironella, Christian Bressy, et al.. (2017). PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. Cellular and Molecular Life Sciences. 74(22). 4231–4243. 28 indexed citations

15.

Lazorthes, F, et al.. (1990). Distal intramural spread of carcinoma of the rectum correlated with lymph nodal involvement.. PubMed. 170(1). 45–8. 26 indexed citations

16.

Reginato, Antonio J., et al.. (1987). Le torus mandibularis. Bulletins et Mémoires de la Société d anthropologie de Paris. 4(1). 25–32. 1 indexed citations

17.

Touboul, P, et al.. (1971). [Wolff-Parkinson-White syndrome. Evidence of an accessory auriculoventricular tract obtained by recording of the potential of the bundle of His].. PubMed. 64(5). 638–56. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact